3 Stocks That Recently Raised Their Guidance for the Year
GDP grew at a rate of 2.4% in the second quarter as the economy did better than expected. And many businesses are also seeing strong demand for their products and services. That, in turn, leads to upgraded forecasts and better outlooks for the entire year.
AbbVie (NYSE: ABBV), Coca-Cola (NYSE: KO), and DoorDash (NYSE: DASH) all recently boosted their projections for 2023. Here's a look at why they are more optimistic about the future, and whether you should consider adding these stocks to your portfolio.
Drugmaker AbbVie is looking at a tough year with sales of its top drug Humira expected to fall significantly amid an increase in competition. With biosimilars becoming available, the drug's market share will take a big hit. But the situation isn't as dire as the company's original forecast suggested.
Source Fool.com
AbbVie Inc. Stock
The stock is an absolute favorite of our community with 32 Buy predictions and no Sell predictions.
As a result the target price of 180 € shows a slightly positive potential of 7.09% compared to the current price of 168.08 € for AbbVie Inc..
